journal article·2014-02

FABRICATION AND IN VITRO EVALUATION OF FOLATE-MODIFIED IRON FERRITE NANOPARTICLES WITH HIGH DOXORUBICIN LOADING FOR RECEPTORS-MAGNETIC-GUIDED DRUG DELIVERY

LIN GUO, WENCE DING, FANDIAN MENG

Nano· Volume 09· Issue 02
Publisher page

Abstract

Folate-modified iron ferrite nanoparticles with high doxorubicin loading (FDMP) were developed for dual targeting of tumor cells. Large quantities of doxorubicin and folate ligand were chemically coupled to the synthesized dual-functional magnetic nanoparticles by using the multihand cross-linker poly-L-glutamic acid. FDMP exhibits high drug loading ability, narrow size distribution and pH sensitivity to drug release. The drug loading ratio and the magnetic response can be adjusted by controlling the reactant ratio. FDMP possesses high magnetic-guided ability and exhibits enhanced uptake by folate receptors expressing tumor cells and increased cancer cell cytotoxicity.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Graphene and Nanomaterials Applications · Nanomaterials for catalytic reactions

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Key Laboratory of Mesoscopic Chemistry of MOE and School of Chemistry and Chemical Engineering, Nanjing University, Nanjing 210093, P. R. China

References (31)

Show source-provided references
1. 10.1038/nnano.2007.38710.1038/nnano.2007.387 ↗
2. 10.1002/adma.20120083210.1002/adma.201200832 ↗
3. Park J. W. · Clin. Cancer Res. · 8 · 1172
4. 10.1021/ja802003h10.1021/ja802003h ↗
5. 10.1021/ja054445510.1021/ja0544455 ↗
6. 10.1016/j.biomaterials.2009.02.01110.1016/j.biomaterials.2009.02.011 ↗
7. 10.1021/ar700081510.1021/ar7000815 ↗
8. 10.1016/S1748-0132(07)70084-110.1016/S1748-0132(07)70084-1 ↗
9. Alexiou C. · Cancer Res. · 60 · 6641
10. 10.1021/nl202721q10.1021/nl202721q ↗
11. 10.1002/adma.20110350510.1002/adma.201103505 ↗
12. 10.1016/j.ijpharm.2008.08.02010.1016/j.ijpharm.2008.08.020 ↗
13. Mikhaylov G. · Nat. Nanotechnol. · 6 · 595
14. 10.1002/adma.20100376310.1002/adma.201003763 ↗
15. 10.1021/ja051736510.1021/ja0517365 ↗
16. 10.1126/science.109583310.1126/science.1095833 ↗
17. 10.1021/la203784510.1021/la2037845 ↗
18. Yang X. · ACS Nano · 11 · 6805
19. 10.1021/bc800396h10.1021/bc800396h ↗
20. 10.1016/j.biomaterials.2008.12.04210.1016/j.biomaterials.2008.12.042 ↗
21. 10.1016/j.jconrel.2006.11.02810.1016/j.jconrel.2006.11.028 ↗
22. 10.1039/b808556k10.1039/b808556k ↗
23. 10.1039/b910439a10.1039/b910439a ↗
24. 10.1038/nnano.2011.14910.1038/nnano.2011.149 ↗
25. M. Mary, Scientific and Clinical Applications of Magnetic Carriers, eds. U. Hafeli, W. Schutt and M. Zborowski (Plenum, Stateplace New York, 1997) p. 303.
26. 10.1021/jp071299b10.1021/jp071299b ↗
27. 10.1016/j.biomaterials.2004.10.01210.1016/j.biomaterials.2004.10.012 ↗
28. 10.1021/nl061412u10.1021/nl061412u ↗
29. 10.1021/cm960157j10.1021/cm960157j ↗
30. 10.1016/j.jmmm.2003.07.00610.1016/j.jmmm.2003.07.006 ↗
31. 10.1111/j.1744-7348.1935.tb07713.x10.1111/j.1744-7348.1935.tb07713.x ↗